- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Pfizer and IIT-Delhi launch incubator
Pfizer and IIT-Delhi have together launched an incubation accelerator initiative at the later's campus for Indian startup companies as well as individuals.
Christened "The Pfizer IIT-Delhi Innovation and IP Program", it comprises two components.
For innovators seeking comprehensive support to translate their healthcare ideas into patents, the programme will provide two years of residential incubation at IIT-Delhi, funding of up to Rs.50 lakh for each innovator, mentoring support from IIT-Delhi's faculty, access to infrastructure and prototyping laboratories, IP search and filing services, guidance from Pfizer's global experts, and access to venture capitalists and other industry linkages.
For innovators who already have a ready proof of concept and are seeking to obtain a patent, the programme will provide access to IP attorneys and services and cover the patent fee.
The programme will invite two rounds of proposals during 2015-2016. Call for proposals for the first round will open from November 27 until January 15, 2016.
An independent panel of subject matter experts will review and shortlist the potential incubates while the Technology Business Incubator Unit board at IIT Delhi Delhi will make the final selection of individuals and startups.
Two rounds of proposals will be invited during 2015-16. Call for proposals for the first round will open on November 27 and will remain open until January 15, 2016, as reported by the Hindu Business Line.
"The objective of this project is to create awareness about innovations in the field of healthcare developed by Indians. Our efforts are in sync with the government's priority of creating a vibrant innovation system in the country and intend to enhance the creation of intellectual property," said S Sridhar, executive director, Pfizer India, as reported by Financial Chronicle.
Speaking on the occasion, "Accelerating manufacturing is a key challenge in India. In order to become the hub of design and innovation, we must ensure that project initiators find adequate funding from investors and venture capitalists. Also, sufficient incubation centres must be set up, which provide good mentoring to the young innovators."
Christened "The Pfizer IIT-Delhi Innovation and IP Program", it comprises two components.
For innovators seeking comprehensive support to translate their healthcare ideas into patents, the programme will provide two years of residential incubation at IIT-Delhi, funding of up to Rs.50 lakh for each innovator, mentoring support from IIT-Delhi's faculty, access to infrastructure and prototyping laboratories, IP search and filing services, guidance from Pfizer's global experts, and access to venture capitalists and other industry linkages.
For innovators who already have a ready proof of concept and are seeking to obtain a patent, the programme will provide access to IP attorneys and services and cover the patent fee.
The programme will invite two rounds of proposals during 2015-2016. Call for proposals for the first round will open from November 27 until January 15, 2016.
An independent panel of subject matter experts will review and shortlist the potential incubates while the Technology Business Incubator Unit board at IIT Delhi Delhi will make the final selection of individuals and startups.
Two rounds of proposals will be invited during 2015-16. Call for proposals for the first round will open on November 27 and will remain open until January 15, 2016, as reported by the Hindu Business Line.
"The objective of this project is to create awareness about innovations in the field of healthcare developed by Indians. Our efforts are in sync with the government's priority of creating a vibrant innovation system in the country and intend to enhance the creation of intellectual property," said S Sridhar, executive director, Pfizer India, as reported by Financial Chronicle.
Speaking on the occasion, "Accelerating manufacturing is a key challenge in India. In order to become the hub of design and innovation, we must ensure that project initiators find adequate funding from investors and venture capitalists. Also, sufficient incubation centres must be set up, which provide good mentoring to the young innovators."
Executive DirectorIIT Delhiincubation acceleratorpatentspfizerS SridharThe Pfizer IIT-Delhi Innovation and IP Program
Next Story